News | January 26, 2010

Government Selects Vendor for U.S. Supply of Nuclear Imaging Isotope

January 26, 2010 – The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) selected GE Hitachi Nuclear Energy (GEH) to help develop a U.S. supply of a radioisotope used in more than 20 million annual, domestic diagnostic medical procedures.

NNSA chose GEH to help create a reliable U.S. supply of molybdenum-99 (Mo-99) without the use of highly enriched uranium (HEU) to respond to a shortage from repeated, unplanned outages at facilities where it currently is produced.

Mo-99 is the precursor of technetium-99m, the radioisotope most widely used in nuclear medicine diagnostic procedures. It is used for the detection of cancer, heart disease and thyroid disease, along with the study of brain and kidney function and the imaging of stress fractures, according to the Society of Nuclear Medicine.

GEH’s new technology does not rely on the fissioning of HEU, advancing a key nonproliferation initiative for the United States. Because GEH’s technology can be used in existing nuclear reactors, the need to build new reactors dedicated to isotope production is reduced.

“NNSA is committed to supporting technology that offers a new path forward for the creation of a reliable, domestic supply of molybdenum-99 without the use of HEU,” said NNSA Administrator Thomas D'Agostino. “This pragmatic approach addresses a critical U.S. medical community need while supporting President Obama's goal of reducing the risk posed by global use of HEU.”

Deploying GEH’s isotope production technology potentially could meet at least 50 percent of the United States’ projected supply needs for the isotope to help ensure patient access to vital medical diagnostic procedures. GEH will conduct research and development to confirm its technology at commercial scale and determine the infrastructure and logistics needed to support commercial operation.

“We are seeking some short-term solutions that have long-term potential, and the GEH technical solution provides a path forward that is quite attractive to meet both these needs,” said Robert Atcher, M.D., Ph.D., past president of the Society of Nuclear Medicine, who evaluated GEH’s isotope technology.

With a half-life of only 66 hours, Mo-99 must be delivered to hospitals on a frequent and consistent basis. Mo-99 decays into technetium-99m, the radioisotope used in about 80 percent of all nuclear medicine procedures.

“We are pleased to work with NNSA to address this isotope challenge,” said Chris Monetta, GEH senior vice president, advanced programs, nuclear fuel cycle. “Our technical approach holds great promise for helping to ensure that a safe and reliable supply of molybdenum is available to help doctors care for their patients.”

GE has more than a half-century of experience in providing isotopes for medical and industrial applications. The GE Test Reactor (GETR), which began operating in 1959, was the first commercially licensed test reactor in the world. GE developed many of the standards and specifications used in the isotope market today. As a result of work performed at GETR, GE produced 30 isotopes, including Mo-99, for medical and industrial uses.

GEH recently announced a landmark agreement with Exelon Generation Company for a pilot project to meet growing demand for cobalt-60, a radioisotope used for treating cancer and other biomedical applications.

For more information: www.gepower.com

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
Sponsored Content | Videos | Business| July 13, 2017
Randall Thompson, M.D., outlines three new CPT codes for FFR-CT, a smart phone-based single-lead ECG system and PET n
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging| July 07, 2017
Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are major causes of...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
cardiac nuclear myocardial perfusion imaging (MIP) exam guidelines for women
News | Nuclear Imaging| June 15, 2017
June 15, 2017 — The American Society of Nuclear Cardiology (ASNC) has published an updated consensus statement on evi
Philips Dosewise portal allows X-ray radiation dose tracking for individual patients

An example of radiation dose tracking software is Philips Dosewise portal, which allows X-ray radiation dose tracking for individual patients by modality, body region and exam type.

Feature | Radiation Dose Management| June 13, 2017 | Dominic Siewko
In recent years, radiation dose management awareness has heightened across the healthcare industry to address growing
MIM Software Inc. Announces Updates to MIM Encore
Technology | Remote Viewing Systems| May 31, 2017
MIM Software Inc. recently announced significant updates to its MIM Encore solution for viewing nuclear medicine images...
Overlay Init